H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 74 Citations 20,905 284 World Ranking 865 National Ranking 43
Medicine D-index 89 Citations 30,536 494 World Ranking 6391 National Ranking 298

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Disease
  • Gene

Margitta Worm spends much of her time researching Allergy, Immunology, Internal medicine, Anaphylaxis and Surgery. Her Allergy research integrates issues from Dermatology, Guideline, Pediatrics and Intensive care medicine. She works mostly in the field of Immunology, limiting it down to concerns involving Disease and, occasionally, Epidemiology.

The various areas that Margitta Worm examines in her Internal medicine study include Placebo, Allergen and Endocrinology. Margitta Worm interconnects Randomized controlled trial and Dupilumab in the investigation of issues within Placebo. In her study, Incidence and Allergists is strongly linked to Systematic review, which falls under the umbrella field of Anaphylaxis.

Her most cited work include:

  • Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis (748 citations)
  • Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis (748 citations)
  • EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy (626 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Immunology, Allergy, Dermatology, Anaphylaxis and Internal medicine. Margitta Worm combines subjects such as Guideline, Provocation test and Asthma with her study of Allergy. Her Dermatology research is mostly focused on the topic Atopic dermatitis.

Her Anaphylaxis research incorporates elements of Epinephrine, Epidemiology, Hypersensitivity reaction and Intensive care medicine. Her biological study deals with issues like Placebo, which deal with fields such as Randomized controlled trial. Her Immunoglobulin E study incorporates themes from Molecular biology and CD40.

She most often published in these fields:

  • Immunology (28.44%)
  • Allergy (26.58%)
  • Dermatology (17.62%)

What were the highlights of her more recent work (between 2019-2021)?

  • Anaphylaxis (17.47%)
  • Allergy (26.58%)
  • Severe acute respiratory syndrome coronavirus 2 (3.71%)

In recent papers she was focusing on the following fields of study:

The scientist’s investigation covers issues in Anaphylaxis, Allergy, Severe acute respiratory syndrome coronavirus 2, 2019-20 coronavirus outbreak and Internal medicine. Her research in Anaphylaxis intersects with topics in Epinephrine, Family medicine, Intensive care medicine, Vaccination and Pediatrics. Her research integrates issues of Clinical trial and Asthma in her study of Allergy.

Her biological study spans a wide range of topics, including Gastroenterology, Placebo and Atopic dermatitis. The study incorporates disciplines such as Dermatology Life Quality Index, Clinical endpoint, Randomized controlled trial and Eczema Area and Severity Index in addition to Placebo. Her work on Allergen immunotherapy, Immunoglobulin E and Allergen as part of her general Immunology study is frequently connected to Current, thereby bridging the divide between different branches of science.

Between 2019 and 2021, her most popular works were:

  • The role of mobile health technologies in allergy care: An EAACI position paper (35 citations)
  • Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial. (25 citations)
  • ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - an EAACI-ARIA position paper. (16 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Gene

Margitta Worm focuses on Anaphylaxis, Allergy, Intensive care medicine, Severe acute respiratory syndrome coronavirus 2 and Internal medicine. The study incorporates disciplines such as Reimbursement, Epinephrine, Multivariate analysis, Vaccination and Secondary prevention in addition to Anaphylaxis. Her work carried out in the field of Allergy brings together such families of science as Adverse effect, Asthma, Emergency medicine and Clinical trial.

As part of the same scientific family, Margitta Worm usually focuses on Clinical trial, concentrating on Placebo and intersecting with Severity of illness, Regimen and Eczema Area and Severity Index. Her Internal medicine study frequently links to related topics such as Atopic dermatitis. Her work deals with themes such as Benralizumab and Position paper, which intersect with Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy

A Muraro;T Werfel;K Hoffmann-Sommergruber;G Roberts;G Roberts;G Roberts.
Allergy (2014)

1058 Citations

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck.
The New England Journal of Medicine (2016)

940 Citations

Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology

A. Muraro;G. Roberts;M. Worm;M. B. Bilo.
Allergy (2014)

867 Citations

Impact of gender on asthma in childhood and adolescence: a GA2LEN review.

Almqvist C;Worm M;Leynaert B.
Allergy (2007)

615 Citations

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

Alain Didier;Hans-Jörgen Malling;Margitta Worm;Friedrich Horak.
The Journal of Allergy and Clinical Immunology (2007)

612 Citations

IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.

D Schadendorf;A Möller;B Algermissen;M Worm.
Journal of Immunology (1993)

566 Citations

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

Diamant Thaçi;Eric L Simpson;Lisa A Beck;Thomas Bieber.
The Lancet (2016)

506 Citations

Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march.

Ingo Marenholz;Renate Nickel;Franz Rüschendorf;Florian Schulz.
The Journal of Allergy and Clinical Immunology (2006)

485 Citations

Direct access to CD4 + T cells specific for defined antigens according to CD154 expression

Marco Frentsch;Olga Arbach;Dennis Kirchhoff;Beate Moewes.
Nature Medicine (2005)

483 Citations

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

F. Estelle R. Simons;Motohiro Ebisawa;Mario Sanchez-Borges;Bernard Y. Thong.
World Allergy Organization Journal (2015)

439 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Margitta Worm

Pascal Demoly

Pascal Demoly

University of Montpellier

Publications: 159

Graham Roberts

Graham Roberts

University of Southampton

Publications: 153

Jean Bousquet

Jean Bousquet

Inserm : Institut national de la santé et de la recherche médicale

Publications: 128

Emma Guttman-Yassky

Emma Guttman-Yassky

Icahn School of Medicine at Mount Sinai

Publications: 107

Nikolaos G. Papadopoulos

Nikolaos G. Papadopoulos

University of Manchester

Publications: 104

Ludger Klimek

Ludger Klimek

Ghent University

Publications: 101

Moises A. Calderon

Moises A. Calderon

National Institutes of Health

Publications: 95

Torsten Zuberbier

Torsten Zuberbier

Charité - University Medicine Berlin

Publications: 93

Rudolf Valenta

Rudolf Valenta

Medical University of Vienna

Publications: 92

Cezmi A. Akdis

Cezmi A. Akdis

University of Zurich

Publications: 87

Giorgio Walter Canonica

Giorgio Walter Canonica

Humanitas University

Publications: 87

Thomas Werfel

Thomas Werfel

Hannover Medical School

Publications: 86

Stephen R. Durham

Stephen R. Durham

Imperial College London

Publications: 85

Claus Bachert

Claus Bachert

Ghent University

Publications: 84

Aziz Sheikh

Aziz Sheikh

University of Edinburgh

Publications: 83

Antonella Muraro

Antonella Muraro

University of Padua

Publications: 75

Something went wrong. Please try again later.